A detailed history of King Luther Capital Management Corp transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, King Luther Capital Management Corp holds 801,994 shares of TMO stock, worth $428 Million. This represents 2.13% of its overall portfolio holdings.

Number of Shares
801,994
Previous 814,347 1.52%
Holding current value
$428 Million
Previous $432 Million 7.84%
% of portfolio
2.13%
Previous 2.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$528.82 - $599.43 $6.53 Million - $7.4 Million
-12,353 Reduced 1.52%
801,994 $466 Million
Q4 2023

Feb 09, 2024

SELL
$431.41 - $532.94 $26 Million - $32.1 Million
-60,274 Reduced 6.89%
814,347 $432 Million
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $3.8 Million - $4.38 Million
-7,624 Reduced 0.86%
874,621 $443 Million
Q2 2023

Aug 10, 2023

SELL
$508.46 - $591.13 $12 Million - $13.9 Million
-23,529 Reduced 2.6%
882,245 $460 Million
Q1 2023

May 11, 2023

SELL
$535.0 - $604.82 $3.03 Million - $3.43 Million
-5,667 Reduced 0.62%
905,774 $522 Million
Q4 2022

Feb 13, 2023

SELL
$484.71 - $571.37 $5.76 Million - $6.79 Million
-11,881 Reduced 1.29%
911,441 $502 Million
Q3 2022

Nov 10, 2022

SELL
$507.19 - $604.49 $1.99 Million - $2.37 Million
-3,921 Reduced 0.42%
923,322 $468 Million
Q2 2022

Aug 11, 2022

SELL
$500.9 - $612.21 $9.15 Million - $11.2 Million
-18,267 Reduced 1.93%
927,243 $504 Million
Q1 2022

May 11, 2022

SELL
$524.0 - $644.92 $31.2 Million - $38.4 Million
-59,618 Reduced 5.93%
945,510 $558 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $9.76 Million - $11.4 Million
-17,152 Reduced 1.68%
1,005,128 $671 Million
Q3 2021

Nov 10, 2021

SELL
$509.53 - $609.78 $5.42 Million - $6.49 Million
-10,636 Reduced 1.03%
1,022,280 $584 Million
Q2 2021

Aug 13, 2021

SELL
$441.0 - $508.24 $5.13 Million - $5.92 Million
-11,640 Reduced 1.11%
1,032,916 $521 Million
Q1 2021

May 12, 2021

SELL
$439.85 - $518.83 $38.9 Million - $45.9 Million
-88,465 Reduced 7.81%
1,044,556 $477 Million
Q4 2020

Feb 10, 2021

SELL
$435.06 - $527.66 $21 Million - $25.5 Million
-48,321 Reduced 4.09%
1,133,021 $528 Million
Q3 2020

Nov 12, 2020

SELL
$359.77 - $441.52 $8.03 Million - $9.85 Million
-22,318 Reduced 1.85%
1,181,342 $522 Million
Q2 2020

Aug 12, 2020

SELL
$275.2 - $362.34 $1.71 Million - $2.26 Million
-6,229 Reduced 0.51%
1,203,660 $436 Million
Q1 2020

May 13, 2020

SELL
$255.3 - $340.05 $20.8 Million - $27.7 Million
-81,579 Reduced 6.32%
1,209,889 $343 Million
Q4 2019

Feb 12, 2020

SELL
$271.93 - $328.04 $683,903 - $825,020
-2,515 Reduced 0.19%
1,291,468 $420 Million
Q3 2019

Nov 12, 2019

SELL
$268.46 - $305.43 $765,916 - $871,391
-2,853 Reduced 0.22%
1,293,983 $377 Million
Q2 2019

Aug 12, 2019

SELL
$257.51 - $295.55 $808,066 - $927,435
-3,138 Reduced 0.24%
1,296,836 $381 Million
Q1 2019

May 10, 2019

SELL
$212.17 - $273.72 $5.46 Million - $7.04 Million
-25,712 Reduced 1.94%
1,299,974 $356 Million
Q4 2018

Feb 12, 2019

SELL
$208.47 - $251.98 $1.77 Million - $2.14 Million
-8,478 Reduced 0.64%
1,325,686 $297 Million
Q3 2018

Nov 13, 2018

SELL
$205.57 - $244.32 $4.59 Million - $5.46 Million
-22,334 Reduced 1.65%
1,334,164 $326 Million
Q2 2018

Aug 13, 2018

SELL
$203.14 - $219.53 $11.4 Million - $12.3 Million
-56,083 Reduced 3.97%
1,356,498 $281 Million
Q1 2018

May 08, 2018

SELL
$192.98 - $224.11 $5.63 Million - $6.54 Million
-29,172 Reduced 2.02%
1,412,581 $292 Million
Q4 2017

Feb 12, 2018

SELL
$182.03 - $200.37 $4.37 Million - $4.81 Million
-24,018 Reduced 1.64%
1,441,753 $274 Million
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $252 Million - $284 Million
1,465,771
1,465,771 $277 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $209B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.